FDA Inspection 768948 — Intermax Pharmaceuticals, Inc.
The FDA completed an inspection of Intermax Pharmaceuticals, Inc. on February 21, 2012 in Farmingdale, NY. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- February 21, 2012
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Farmingdale, NY (United States)